Severity: Warning
Message: fopen(/home/oaponnap/tmp/ci_session0612f3cfb76077142a88ec6127231635): failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 157
Backtrace:
File: /home/oaponnap/public_html/innovationinfo.org/application/controllers/Journal.php
Line: 11
Function: __construct
File: /home/oaponnap/public_html/innovationinfo.org/index.php
Line: 315
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /home/oaponnap/tmp)
Filename: Session/Session.php
Line Number: 141
Backtrace:
File: /home/oaponnap/public_html/innovationinfo.org/application/controllers/Journal.php
Line: 11
Function: __construct
File: /home/oaponnap/public_html/innovationinfo.org/index.php
Line: 315
Function: require_once
Name: Serena Pellegatta
Educational Qualification: Ph.D.
Designation: Head of Laboratory
Department: Unit of Molecular Neuro-Oncology
Fondazione IRCCS Istituto Neurologico Carlo Besta
Email: serena.pellegatta@istituto-besta.it
Research Interests: Cancer immunotherapy, T and CAR T cell-based therapy and gene therapy, Tumor microenvironment and Tumor infiltrating lymphocytes (TILs).
Biography: Serena Pellegatta is currently working Head of Laboratory of “Immunotherapy of Brain Tumors” at Fondazione IRCCS Istituto Neurologico Carlo Besta in Milan, Italy. She obtained her Ph.D. in Translational and Molecular Medicine, University of Milan Bicocca. She has experience in Dendritic Cell Immunotherapy and CAR-T cell therapy for the treatment of brain tumors, with particular attention to glioblastoma. At the preclinical levels, her major interests are the mechanisms of immunotherapy resistance and the interaction between glioblastoma and immune system. At the clinical levels, she is responsible for the immune monitoring of patients involved in clinical studies based on dendritic cell immunotherapy.
Serial no:IIEBM0602